Viksnins Harris Padys Malen LLP
Compounds useful for treating gastrointestinal tract disorders
The present disclosure is directed to compounds and methods for the treatment of disorders associated with fluid retention or salt overload, such as heart failure (in particular, congestive heart failure), chronic kidney disease, end-stage renal disease, liver disease, and peroxisome proliferator-activated receptor (PPAR) gamma agonist-induced fluid retention. The present disclosure is also directed to compounds and methods for the treatment of hypertension. The present disclosure is also directed to compounds and methods for the treatment of gastrointestinal tract disorders, including the treatment or reduction of pain associated with gastrointestinal tract disorders.
ARDELYX, INC.
C A C C C C C C C C A A C C A A A C C A C C
C07D A61P C07D C07D C07D C07D C07D C07D C07D C07D A61P A61P C07D C07D A61P A61P A61P C07D C07D A61K C07D C07D
inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional
Irina Jason Dean
Dotsenko Lewis Dragoli